Joshua T Brumm Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joshua T Brumm.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joshua T Brumm. Joshua T Brumm is a VP of Corporate Development in Zeltiq Aesthetics Inc ($ZLTQ) and a Chief Financial Officer in Versartis, Inc. ($VSAR) and a COO and CFO in Versartis, Inc. ($VSAR) and a See Remarks in Kaleido Biosciences, Inc. ($KLDO) and a See Remarks in Dyne Therapeutics, Inc. ($DYN).
Address: 4698 WILLOW ROAD SUITE 100 PLEASANTON 94588 CA
Companies in which Joshua T Brumm is an Insider
Aravive, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joshua T Brumm: COO and CFO, Chief Financial Officer
Holdings: 201,269 shares
Current Value: $2,676,878
Latest Transaction: Oct 23 2017
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dyne Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joshua T Brumm: See Remarks
Holdings: 107,027 shares
Latest Transaction: Sep 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kaleido Biosciences, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Joshua T Brumm: See Remarks
Holdings: 0 shares
Latest Transaction: Mar 04 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zeltiq Aesthetics Inc
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of Joshua T Brumm: VP of Corporate Development
Holdings: 7,692 shares
Current Value: $348,063
Latest Transaction: Apr 30 2012
$ZLTQ Market Capitalization: $1.85B
$ZLTQ Previous Close: $45.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Joshua T Brumm
Sentiment: All, ARAV, DYN, KLDO, ZLTQ
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18 2020 | DYN | Dyne Therapeutics, ... | Brumm Joshua T | See Remarks | Option Exercise | A | 19.00 | 320,781 | 6,094,839 | 320,781 | |
| Sep 18 2020 | DYN | Dyne Therapeutics, ... | Brumm Joshua T | See Remarks | Grant | A | 0.00 | 107,027 | 0 | 107,027 | 0 to 107 K |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | Brumm Joshua T | See Remarks | Option Exercise | A | 15.00 | 80,000 | 1,200,000 | 80,000 | |
| Oct 23 2017 | VSAR | Versartis, Inc. | Brumm Joshua T | COO and CFO | Sell | S | 2.55 | 1,326 | 3,381 | 201,269 | 202.6 K to 201.3 K (-0.65 %) |
| Oct 10 2017 | VSAR | Versartis, Inc. | Brumm Joshua T | COO and CFO | Grant | A | 0.00 | 97,000 | 0 | 202,595 | 105.6 K to 202.6 K (+91.86 %) |
| Jun 14 2017 | VSAR | Versartis, Inc. | Brumm Joshua T | COO and CFO | Sell | S | 16.05 | 1,421 | 22,807 | 105,595 | 107 K to 105.6 K (-1.33 %) |
| May 17 2017 | VSAR | Versartis, Inc. | Brumm Joshua T | COO and CFO | Sell | S | 17.40 | 1,263 | 21,976 | 107,016 | 108.3 K to 107 K (-1.17 %) |